| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3849752 | American Journal of Kidney Diseases | 2011 | 7 Pages |
Abstract
In hemodialysis patients without preexisting IHD, β-blocker use was not associated with lower risk of sudden cardiac death. However, there was a trend toward benefit in those with IHD.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Navdeep MD, FRCP(C), Shani MD, MS, Hocine MS, Gerald J. PhD, Alfred K. MD, Garabed MD, Mark J. MD, MS,